Lab Manager | Run Your Lab Like a Business

CardioTech to sell biomedical unit

CardioTech International Inc. on Thursday said it will sell its Gish Biomedical Unit after the company posted a narrower third quarter loss.

CardioTech's CEO, Michael Adams, called the biomedical unit a "great bus

Register for free to listen to this article
Listen with Speechify
0:00
5:00

CardioTech International Inc. on Thursday said it will sell its Gish Biomedical Unit after the company posted a narrower third quarter loss.

CardioTech's CEO, Michael Adams, called the biomedical unit a "great business," but not in line with the company's strategic direction.

Gish, makes disposable medical products for various specialties; including cardiovascular surgery, orthopedics and oncology.

Source: BusinessWeek